Pak court indicts Musharraf; rejects plea to travel abroad

April 1, 2014

Indicts_MusharrafIslamabad, Apr 1: In a double whammy, former dictator Pervez Musharraf was today indicted by a court on five counts of high treason and his plea to travel abroad rejected as he became Pakistan's first ever military ruler to face criminal prosecution that entails death penalty.

Musharraf, who personally appeared in the special court for the second time since proceedings began in December, pleaded "not guilty" to all the charges against him read out by Justice Tahira Safdar of the Balochistan High Court.

The high-profile treason case against the 70-year-old former president is seen as a setback for the country's powerful army that apparently looked like moving to protect Musharraf when he was shifted to a military hospital in early January.

Musharraf is accused of treason for suspending, subverting and abrogating the Constitution, imposing an emergency in the country in November 2007 and detaining judges of superior courts.

If found guilty, he faces the death sentence or life imprisonment.

Reading out from his notes, Musharraf said that he gave 44 years of his life to the Pakistan Army and made defence invincible. He said he gave repute and progress to the country.

"I honour this court and prosecution, I strongly believe in law, I don't have ego problems and I have appeared in court 16 times in this year in Karachi, Islamabad and Rawalpindi," Musharraf said.

"I am being called a traitor, I have been chief of army staff for nine years and I have served this army for 45 years. I have fought two wars and it is treason?," he questioned.

Prosecutor Akram Sheikh in reply said he has never used the word "traitor".

Amid tight security, the three-judge bench headed by Justice Faisal Arab of the Sindh High Court read out the indictment against Musharraf.

Prior to the indictment, Farogh Naseem, a new lawyer in Musharraf's defence team, requested the court to allow the former president to travel to the UAE to meet his 95-year-old ailing mother.

Rejecting his application for seeking permission to travel abroad, the special court ruled that it did not have the powers to do so as it was functioning under a specific law.

Musharraf came to power in a bloodless coup in 1999, deposing then-prime minister Nawaz Sharif.

Musharraf, facing impeachment following elections in 2008, resigned as president and went into self-imposed exile in Dubai.

The court ruled that it did not put Musharraf's name on the Exit Control List (ECL) and a review can be done by the federal government.

Anybody whose name is on ECL cannot leave the country without permission.

The court said Musharraf is not in its custody and he is a free man.

Postponing the hearing to April 14, the court said he will have to appear before it as and when asked to do so.

However, it ruled that exemption can also be granted on specific days in case of a justifiable reason.

Security measures at the court were beefed up in anticipation of Musharraf's appearance in court, in compliance with an order issued on March 14, demanding his presence enforced or voluntary in the dock.

Musharraf was admitted to the Armed Forces Institute of Cardiology (AFIC), Rawalpindi, on January 2 after he complained of "heart problem" on his way to the court.

Following the hearing, Musharraf was rushed back to the hospital in Rawalpindi accompanied by a security convoy of dozens of vehicles and government-provided security personnel.

The military has ruled Pakistan for about half of its 66-year history and no ruler or top military commander has ever faced criminal prosecution before Musharraf.

Musharraf said the real "ghaddar" (traitor) are those who create hindrances in the country's socio-economic development and those who looted the national exchequer.

Musharraf in his defence said he had spent night with soldiers in Siachen and Kargil.

He proudly claimed to a former member of the Special Services Group whose moto was "ghazi and shaheed" (to kill or be a martyr).

He also listed out the steps that he had taken for the betterment of the country.

While commenting on the indictment of Musharraf, Cabinet Minister Ahsan Iqbal said Pakistan made another history.

"For the first time trial against a dictator brought him to face charges in court. It is a victory for all those who refused to bow against dictatorship, struggled and sacrificed to uphold the cause of rule of law in Pakistan," Iqbal said.

Iqbal, in a Facebook message, said Musharraf still showed his contempt for law and cowardice by trying to escape appearances.

"If Mush (Musharraf) had shown courage to appear on first call, he would have saved personal embarrassment and millions of rupees. But if he was so wise, why would he impose emergency in the first place," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 15,2020

May 15: Global deaths linked to the novel coronavirus passed 300,000 on Thursday, while reported cases of the virus are approaching 4.5 million, according to a news agency tally.

About half of the fatalities have been reported by the United States, the United Kingdom and Italy.

The first death linked to the disease was reported on January 10 in Wuhan, China. It took 91 days for the death toll to pass 100,000 and a further 16 days to reach 200,000, according to the Reuters tally of official reports from governments. It took 19 days to go from 200,000 to 300,000 deaths.

By comparison, an estimated 400,000 people die annually from malaria, one of the world’s most deadly infectious diseases.

The United States had reported more than 85,000 deaths from the new coronavirus, while the United Kingdom and Italy have reported over 30,000 fatalities each.

While the current trajectory of COVID-19 falls far short of the 1918 Spanish flu, which infected an estimated 500 million people, killing at least 10% of patients, public health experts worry the available data is underplaying the true impact of the pandemic.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Beijing, June 30: China said on Tuesday it was concerned about India’s decision to ban Chinese mobile apps such as Bytedance’s TikTok and Tencent’s WeChat and was making checks to verify the situation.

Chinese foreign ministry spokesman Zhao Lijian told reporters during a daily briefing that (the Prime Minister Narendra Modi-led government of) India has a responsibility to uphold the rights of Chinese businesses.

India on Monday banned 59, mostly Chinese, mobile apps in its strongest move yet targeting China in the online space since a border crisis erupted between the two countries this month.

The apps are “prejudicial to the sovereignty and integrity of India, the defence of India, the security of state and public order", the ministry of information technology said in a statement, which came two weeks after 20 Indian Army personnel were killed in a violent clash on the India-China border in Ladakh.

The companies have been invited to offer clarifications before a government panel, which will decide whether the ban can be removed or will stay.

The move also came ahead of military and diplomatic talks between India and China scheduled this week.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.